Joshua S. Prince - Jun 30, 2025 Form 4 Insider Report for Vistagen Therapeutics, Inc. (VTGN)

Role
Chief Operating Officer
Signature
/s/ Cynthia Anderson, Attorney-in-Fact
Stock symbol
VTGN
Transactions as of
Jun 30, 2025
Transactions value $
$8,299
Form type
4
Date filed
7/1/2025, 05:51 PM
Previous filing
Jun 25, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Prince Joshua S. Chief Operating Officer C/O VISTAGEN THERAPEUTICS, INC., 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO /s/ Cynthia Anderson, Attorney-in-Fact 2025-07-01 0001998663

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $8.3K +4.88K +81.63% $1.70 10.9K Jun 30, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d).